• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • PROs
    • Menopause Rating Scale
      • Menopause Rating Scale (MRS) – Languages
    • Aging Male Symptoms Scale
      • AMS – properties as an outcome measure
      • AMS – properties as a screening tool
    • Quality of Sexual Function Scale
      • Quality of Sexual Function Scale
    • Short Term Hormone Effect Scale
      • Short Term Hormone Effect Scale
    • Research team
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Publications

Assmann Anita, Heinemann Klaas, Dinger Jürgen, The safety of oral hormone replacement therapy: final results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 181.
Rabe T, Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Mueck A O, Albring C, Contraception and thrombophilia - a statement from the german society for gynecological endocrinology and reproductive medicine (DGGEF e.V.) and the professional association of german gynaecologists. J Reproduktionsmed Endokrinol. 2011; 8 (Special Issue 1): 126-167.
Heinemann Klaas, Barnett Clare, Dinger Jürgen, Risk factors for uterine perforations during IUD insertion: interim results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 138.
Heinemann Klaas, Heinemann Lothar A , Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.. J Fam Plann Reprod Health Care. 2011; Jul;37(3):132-5. 10.1136/jfprhc-2011-14524.
Dinger Jürgen, Bardenheuer Kristina, Franke Christian, The risk of VTE in users of a 24-day regimen of a combined oral contraceptive compared to conventional 21-day OC regimes: results from the INAS-OC study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 131.
Dinger Jürgen, EURAS-HRT: cardiovascular and other outcomes - international menopause society. The Journal of Adult Women`s Health & Medicine. 2011; Vol. 14 Supplement 1: 214.
Barnett Clare, Heinemann Klaas, Dinger Jürgen, Complications associated with unintended pregnancies under IUD use: results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 125.
Heinemann Klaas, EURAS-HRT: study design and baseline characteristics - international menopause society. The Journal of Adult Women`s Health & Medicine. 2011; Vol. 14 Supplement 1: 214.
Bardenheuer Kristina, Dinger Jürgen, Leddin Janko, Reasons for oral contraceptives use in adolescents and adults in europe. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 118.
Rabe T, Luxembourg B, Ludwig M, Dinger Jürgen, Bauersachs R, Rott H, Albring C, Risikofaktor Reisethrombose, Umgang mit hormonalen Kontrazeptiva & Indikation zur Thrombophiliediagnostik gyne. Fachzeitschrift für den Arzt der Frau. 2011; 04/2011; 25-29.
Dinger Jürgen, Bardenheuer Kristina, Do Minh Thai, Dose of estrogen and contraceptive failure rates of combined oral contraceptives. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 75.
Dinger Jürgen, Do Minh Thai, Bardenheuer Kristina, Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstetrics and Gynecology. 2011; 117:33-40.
  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Interim pages omitted …
  • Page 22
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Patient Reported Outcomes (PROs)
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2025 ZEG Berlin

Impressum

Website by Laura Yeffeth.